Summary BA. 2.86, a recently identified descendant of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) Omicron BA. 2 sublineage, contains∼ 35 mutations …

Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the …

The hematological effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) are important in COVID-19 pathophysiology. However, the interactions of SARS-CoV-2 …

Introduction The severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike (S)
protein is essential in mediating membrane fusion of the virus with the target cells. Several …

Abstract Since> 3 years, SARS-CoV-2 has plunged humans into a colossal pandemic.
Henceforth, multiple waves of infection have swept through the human population, led by …

The fundamental biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
nucleocapsid protein (Ncap), its use in diagnostic assays and its potential application as a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prolonged the duration
of the pandemic because of the continuous emergence of new variant strains. The …

Since the SARS-CoV-2 Omicron virus has gained dominance worldwide, its continual
evolution with unpredictable mutations and patterns has revoked all authorized …

It is clear that new approaches are needed to promote broadly protective immunity to viral
pathogens, particularly those that are prone to mutation and escape from antibody-mediated …

The recently detected Omicron BA. 2.86 lineage contains more than 30 amino acid
mutations relative to BA. 2. Here, we identify the epitopes driving immune escape of BA. 2.86 …